Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 8 studies | 31% ± 16% | |
interneuron | 4 studies | 29% ± 12% | |
GABAergic neuron | 3 studies | 25% ± 8% | |
granule cell | 3 studies | 31% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 30% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 2649.49 | 2570 / 2642 | 87% | 9.87 | 616 / 705 |
pancreas | 87% | 217.86 | 284 / 328 | 58% | 4.09 | 103 / 178 |
prostate | 73% | 238.24 | 180 / 245 | 52% | 1.34 | 262 / 502 |
adrenal gland | 19% | 61.12 | 48 / 258 | 82% | 27.16 | 188 / 230 |
ovary | 32% | 56.16 | 57 / 180 | 45% | 2.74 | 194 / 430 |
thymus | 11% | 12.29 | 74 / 653 | 57% | 2.72 | 347 / 605 |
skin | 62% | 213.75 | 1121 / 1809 | 2% | 0.19 | 9 / 472 |
esophagus | 30% | 61.95 | 431 / 1445 | 19% | 2.03 | 34 / 183 |
heart | 41% | 96.70 | 356 / 861 | 0% | 0 | 0 / 0 |
kidney | 15% | 18.49 | 13 / 89 | 26% | 1.83 | 231 / 901 |
muscle | 33% | 62.92 | 268 / 803 | 0% | 0 | 0 / 0 |
uterus | 9% | 22.35 | 15 / 170 | 12% | 0.60 | 57 / 459 |
stomach | 8% | 12.23 | 28 / 359 | 6% | 0.46 | 17 / 286 |
breast | 5% | 6.28 | 25 / 459 | 5% | 0.16 | 61 / 1118 |
liver | 0% | 0 | 0 / 226 | 11% | 0.79 | 44 / 406 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.37 | 4 / 45 |
lung | 1% | 0.69 | 4 / 578 | 7% | 1.07 | 79 / 1155 |
intestine | 0% | 0.42 | 3 / 966 | 4% | 0.34 | 23 / 527 |
bladder | 0% | 0 | 0 / 21 | 3% | 0.33 | 17 / 504 |
eye | 0% | 0 | 0 / 0 | 3% | 0.15 | 2 / 80 |
adipose | 2% | 2.06 | 23 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.44 | 6 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007043 | Biological process | cell-cell junction assembly |
GO_0007275 | Biological process | multicellular organism development |
GO_0000902 | Biological process | cell morphogenesis |
GO_0034332 | Biological process | adherens junction organization |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0016477 | Biological process | cell migration |
GO_0044331 | Biological process | cell-cell adhesion mediated by cadherin |
GO_0016339 | Biological process | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO_0005912 | Cellular component | adherens junction |
GO_0016342 | Cellular component | catenin complex |
GO_0045296 | Molecular function | cadherin binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0008013 | Molecular function | beta-catenin binding |
Gene name | CDH22 |
Protein name | Cadherin-22 (Pituitary and brain cadherin) (PB-cadherin) CDH22 protein |
Synonyms | C20orf25 |
Description | FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. PB-cadherins may have a role in the morphological organization of pituitary gland and brain tissues (By similarity). . |
Accessions | Q49AS4 Q9UJ99 ENST00000537909.4 |